vs

Side-by-side financial comparison of Kosmos Energy Ltd. (KOS) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.

Kosmos Energy Ltd. is the larger business by last-quarter revenue ($294.6M vs $151.7M, roughly 1.9× Nutex Health, Inc.). On growth, Kosmos Energy Ltd. posted the faster year-over-year revenue change (-25.9% vs -41.1%). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs -16.5%).

Kosmos Energy is an American upstream oil company founded and based in Dallas, Texas. While previously incorporated in Bermuda, Kosmos has reincorporated in Delaware. The company holds production and development operations offshore Ghana, Equatorial Guinea, and Gulf of Mexico, while holding a development project offshore Mauritania and Senegal, and exploration licenses offshore Namibia, São Tomé and Príncipe and Suriname. It was previously involved in exploration offshore Morocco and Western ...

Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.

KOS vs NUTX — Head-to-Head

Bigger by revenue
KOS
KOS
1.9× larger
KOS
$294.6M
$151.7M
NUTX
Growing faster (revenue YoY)
KOS
KOS
+15.2% gap
KOS
-25.9%
-41.1%
NUTX
Faster 2-yr revenue CAGR
NUTX
NUTX
Annualised
NUTX
50.0%
-16.5%
KOS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
KOS
KOS
NUTX
NUTX
Revenue
$294.6M
$151.7M
Net Profit
$11.8M
Gross Margin
30.4%
Operating Margin
-125.7%
20.4%
Net Margin
7.8%
Revenue YoY
-25.9%
-41.1%
Net Profit YoY
-80.8%
EPS (diluted)
$-0.80
$2.34

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KOS
KOS
NUTX
NUTX
Q4 25
$294.6M
$151.7M
Q3 25
$311.0M
$267.8M
Q2 25
$392.6M
$244.0M
Q1 25
$290.1M
$211.8M
Q4 24
$397.6M
$257.6M
Q3 24
$407.8M
$78.8M
Q2 24
$447.8M
$76.1M
Q1 24
$422.3M
$67.5M
Net Profit
KOS
KOS
NUTX
NUTX
Q4 25
$11.8M
Q3 25
$-124.3M
$55.4M
Q2 25
$-87.7M
$-17.7M
Q1 25
$-110.6M
$21.2M
Q4 24
$61.6M
Q3 24
$45.0M
$-8.8M
Q2 24
$59.8M
$-364.0K
Q1 24
$91.7M
$-364.0K
Gross Margin
KOS
KOS
NUTX
NUTX
Q4 25
30.4%
Q3 25
57.8%
Q2 25
51.2%
Q1 25
55.9%
Q4 24
55.0%
Q3 24
27.8%
Q2 24
29.7%
Q1 24
15.1%
Operating Margin
KOS
KOS
NUTX
NUTX
Q4 25
-125.7%
20.4%
Q3 25
-34.2%
48.7%
Q2 25
-16.2%
13.8%
Q1 25
-32.4%
38.1%
Q4 24
-8.5%
44.4%
Q3 24
26.1%
12.3%
Q2 24
30.2%
7.0%
Q1 24
33.6%
2.1%
Net Margin
KOS
KOS
NUTX
NUTX
Q4 25
7.8%
Q3 25
-40.0%
20.7%
Q2 25
-22.3%
-7.3%
Q1 25
-38.1%
10.0%
Q4 24
23.9%
Q3 24
11.0%
-11.2%
Q2 24
13.3%
-0.5%
Q1 24
21.7%
-0.5%
EPS (diluted)
KOS
KOS
NUTX
NUTX
Q4 25
$-0.80
$2.34
Q3 25
$-0.26
$7.76
Q2 25
$-0.18
$-2.95
Q1 25
$-0.23
$3.33
Q4 24
$0.00
$11.56
Q3 24
$0.09
$-1.72
Q2 24
$0.12
$-0.07
Q1 24
$0.19
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KOS
KOS
NUTX
NUTX
Cash + ST InvestmentsLiquidity on hand
$91.5M
$185.6M
Total DebtLower is stronger
$3.1B
Stockholders' EquityBook value
$528.6M
$329.4M
Total Assets
$4.7B
$918.5M
Debt / EquityLower = less leverage
5.78×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KOS
KOS
NUTX
NUTX
Q4 25
$91.5M
$185.6M
Q3 25
$64.0M
$166.0M
Q2 25
$51.7M
$96.7M
Q1 25
$49.8M
$84.7M
Q4 24
$85.0M
$40.6M
Q3 24
$51.6M
$46.9M
Q2 24
$173.8M
$40.8M
Q1 24
$254.3M
$30.0M
Total Debt
KOS
KOS
NUTX
NUTX
Q4 25
$3.1B
Q3 25
$3.0B
Q2 25
$2.9B
Q1 25
Q4 24
$2.7B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
KOS
KOS
NUTX
NUTX
Q4 25
$528.6M
$329.4M
Q3 25
$898.8M
$317.2M
Q2 25
$1.0B
$235.3M
Q1 25
$1.1B
$176.9M
Q4 24
$1.2B
$132.4M
Q3 24
$1.2B
$60.4M
Q2 24
$1.1B
$62.7M
Q1 24
$1.1B
$63.0M
Total Assets
KOS
KOS
NUTX
NUTX
Q4 25
$4.7B
$918.5M
Q3 25
$5.1B
$964.5M
Q2 25
$5.2B
$841.0M
Q1 25
$5.3B
$761.9M
Q4 24
$5.3B
$655.3M
Q3 24
$5.5B
$438.5M
Q2 24
$5.4B
$422.4M
Q1 24
$5.4B
$404.3M
Debt / Equity
KOS
KOS
NUTX
NUTX
Q4 25
5.78×
Q3 25
3.31×
Q2 25
2.80×
Q1 25
Q4 24
2.29×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KOS
KOS
NUTX
NUTX
Operating Cash FlowLast quarter
$35.3M
$70.4M
Free Cash FlowOCF − Capex
$69.0M
FCF MarginFCF / Revenue
45.5%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
5.95×
TTM Free Cash FlowTrailing 4 quarters
$245.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KOS
KOS
NUTX
NUTX
Q4 25
$35.3M
$70.4M
Q3 25
$-27.6M
$99.5M
Q2 25
$127.2M
$27.3M
Q1 25
$-888.0K
$51.0M
Q4 24
$175.7M
$54.0K
Q3 24
$6.3M
$6.8M
Q2 24
$223.7M
$13.3M
Q1 24
$272.6M
$3.1M
Free Cash Flow
KOS
KOS
NUTX
NUTX
Q4 25
$69.0M
Q3 25
$99.2M
Q2 25
$26.5M
Q1 25
$50.9M
Q4 24
$-341.0K
Q3 24
$6.2M
Q2 24
$12.7M
Q1 24
$2.3M
FCF Margin
KOS
KOS
NUTX
NUTX
Q4 25
45.5%
Q3 25
37.0%
Q2 25
10.9%
Q1 25
24.0%
Q4 24
-0.1%
Q3 24
7.8%
Q2 24
16.7%
Q1 24
3.4%
Capex Intensity
KOS
KOS
NUTX
NUTX
Q4 25
0.9%
Q3 25
0.1%
Q2 25
0.3%
Q1 25
0.0%
Q4 24
0.2%
Q3 24
0.8%
Q2 24
0.7%
Q1 24
1.1%
Cash Conversion
KOS
KOS
NUTX
NUTX
Q4 25
5.95×
Q3 25
1.80×
Q2 25
Q1 25
2.40×
Q4 24
0.00×
Q3 24
0.14×
Q2 24
3.74×
Q1 24
2.97×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KOS
KOS

Ghana Segment$134.6M46%
Gulf Of America$80.7M27%
Mauritania And Senegal$54.9M19%
Equatorial Guinea Segment$24.3M8%

NUTX
NUTX

Hospital Division$143.7M95%
Population Health Management Division$8.0M5%

Related Comparisons